J Korean Med Sci.  2024 Apr;39(15):e142. 10.3346/jkms.2024.39.e142.

Letter to the Editor: A Discussion About Pharmacovigilance Study Methods

• Lee J

• KMID: 2555472
• DOI: http://doi.org/10.3346/jkms.2024.39.e142

Reference

1. Kim DH, Kim JH, Oh IS, Choe YJ, Choe SA, Shin JY. Adverse events following COVID-19 vaccination in adolescents: insights from pharmacovigilance study of VigiBase. J Korean Med Sci. 2024; 39(8):e76. PMID: 38442719.

2. BioNTech Manufacturing GmbH. Comirnaty. EPAR – Risk management plan. Updated 2023. Accessed March 6, 2024. https://www.ema.europa.eu/en/documents/rmp-summary/comirnaty-epar-risk-management-plan_en.pdf .

3. Moderna Biotech Spain SL. Spikevax (previously COVID-19 Vaccine Moderna): EPAR – Risk-management-plan. Updated 2023. Accessed March 6, 2024. https://www.ema.europa.eu/en/documents/rmp-summary/spikevax-previously-covid-19-vaccine-moderna-epar-risk-management-plan_en.pdf .

4. MedDRA. Getting Started with MedDRA (Webinar). Updated 2023. Accessed March 6, 2024. https://www.meddra.org/training-materials .

5. MedDRA. Support Documentation. Updated 2024. Accessed March 6, 2024. https://www.meddra.org/how-to-use/support-documentation/english .

6. Zenodo. AESI Case Definition Companion Guide: Multisystem Inflammatory Syndrome In Children and Adults (MIS-C/A) (V1.0). Updated 2022. Accessed March 6, 2024. DOI: 10.5281/zenodo.7248905.

7. European Medicines Agency. Screening for adverse reactions in EudraVigilance. Updated 2016. Accessed March 6, 2024. https://www.ema.europa.eu/en/documents/other/screening-adverse-reactions-eudravigilance_en.pdf .

8. Kirkwood B, Sterne J. Essential Medical Statistics. 2nd ed. Malden, MA, USA: Blackwell Science;2003.

9. Gaucher L, Sabatier P, Katsahian S, Jannot AS. Pharmacovigilance studies without a priori hypothesis: systematic review highlights inappropriate multiple testing correction procedures. J Clin Epidemiol. 2023; 162:127–134. PMID: 37657615.

10. Bate A, Hornbuckle K, Juhaeri J, Motsko SP, Reynolds RF. Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance. Ther Adv Drug Saf. 2019; 10:2042098619864744. PMID: 31428307.

11. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395(10237):1607–1608. PMID: 32386565.